TL;DR
This study reveals that low-frequency and rare genetic variants, previously overlooked by common variant GWAS, explain a significant portion of multiple sclerosis (MS) heritability. By analyzing a large dataset of cases and controls, the researchers identified novel genes involved in immune regulation, offering new avenues for understanding MS pathogenesis.
What Problem Does This Paper Address?
Multiple sclerosis (MS) is a complex neurological disease with a substantial genetic component, but a significant portion of its heritability remains unexplained by common genetic variants identified through genome-wide association studies (GWAS). While common variants account for about 20% of MS heritability, the remaining heritability is thought to be due to additive effects of other variants, rather than complex interactions or rare family-specific mutations. This paper tackles the challenge of identifying the source of this "missing heritability," specifically focusing on the contribution of low-frequency (MAF 0.0001-5%) and rare coding variants, which are often not well-captured by standard GWAS arrays due to their low frequency and limited linkage disequilibrium with common variants.
Methods
The researchers conducted a large-scale meta-analysis of low-frequency coding variants across all autosomal exons. They utilized a dataset of 68,379 MS cases and 36,012 controls, genotyped using Illumina HumanExome Beadchips or a custom array incorporating exome chip content.
Key methodological steps included:
- Genotyping and Quality Control: Rigorous quality control was applied to filter samples and variants, including checks for genotyping rate, heterozygosity, sex concordance, relatedness, population stratification (using principal component analysis), and Hardy-Weinberg equilibrium.
- Low-Frequency Variant Calling: They employed both Illumina's standard GenCall algorithm and zCall, a specialized algorithm for calling low-frequency variants.
- Association Analysis: Linear mixed models, implemented in GCTA, were used for association analysis within each of 13 country-level strata. This approach accounts for population structure and genetic relatedness.
- Meta-Analysis: Association statistics from the strata were combined using inverse-variance-weighted meta-analysis. A Bonferroni correction was applied for multiple testing to establish a genome-wide significance threshold.
- Heritability Estimation: GCTA was also used to estimate the heritability explained by different variant frequency categories (common, intermediate, and rare) using both two-component and three-component models.
Datasets
The study utilized a large, multi-cohort dataset comprising:
- MS Cases and Controls: A total of 68,379 MS cases and 32,367 MS cases and 36,012 controls were analyzed. These samples were drawn from Australia, ten European countries, and multiple US states.
- Exome Chip Data: Genotyping was performed using Illumina HumanExome Beadchips or a custom array.
- ExAC Database: The Exome Aggregation Consortium (ExAC) database was used to assess the coverage of the exome chip for low-frequency missense variants.
Key Insights and Ideas
- Low-frequency variants are significant contributors to MS risk: The study provides strong evidence that variants with minor allele frequencies (MAF) below 5% are not just noise but actively contribute to MS heritability, a finding that has been difficult to ascertain with traditional GWAS.
- Coding variants are key: By focusing on non-synonymous coding variants, the researchers increased the likelihood of identifying variants with a direct phenotypic impact, making their findings more interpretable and experimentally tractable.
- Novel genes highlight immune pathways: The identification of four novel genes associated with MS risk points to critical roles for T cell homeostasis, IFNγ biology, and NFκB signaling in the pathogenesis of the disease. This moves beyond previously identified loci and suggests new therapeutic targets.
- Low linkage disequilibrium simplifies interpretation: The finding that these low-frequency variants show minimal linkage disequilibrium with common variants means their effects are likely independent, making it easier to pinpoint the causal genes and understand their specific contributions.
Key Results
- Heritability Explained: Low-frequency coding variants explain approximately 5% of MS heritability. Specifically, rare variants (MAF < 1%) alone account for about 3.2% of heritability on the liability scale.
- Novel Gene Discoveries: Seven low-frequency coding variants in six genes outside the extended MHC locus were found to be significantly associated with MS risk. Four of these genes represent novel associations.
- Functional Relevance: The identified genes are involved in key immunological pathways, including perforin-mediated cytotoxicity (PRF1), T regulatory cell development (HDAC7), interferon signaling (PRKRA), and NFκB signaling.
Limitations and Future Work
- Detectability Threshold: While the study identified significant associations, the authors acknowledge that they cannot detect all low-frequency variants at genome-wide significance, even with a large sample size. Many rare variants likely contribute to MS risk but are individually below the statistical threshold for detection.
- Exome Chip Coverage: The exome chip captures a substantial fraction of low-frequency missense variants but has lower coverage for very rare alleles, meaning the heritability estimates for the rarest variants might be conservative.
- Future Directions: The identified genes and pathways provide a rich resource for future research into the pathobiology of MS. Further experimental validation of these variants and genes, and exploration of their functional mechanisms, are crucial next steps. The study also suggests that future genetic studies should continue to prioritize the investigation of low-frequency and rare variants to fully unravel the genetic architecture of complex diseases like MS.
Summary updated